Build, it is nice news, but I would rather have had and in person or tele conf with the FDA. Let's say they come back with a letter saying do this, that and the other thing, but we have already done the other thing, do GNBT now have to write back to them wasting more time? I can't imagine the FDA is not having tele conf calls with companies when dealing with covid vaccines. I would think this is a hot topic and they want to address immediately. Of course, everything is messed up right now, but I just think they are blowing us off like the SEC and BARDA because we are a tiny company with no revenues or products.